140
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Quality of pharmaceutical print advertising in South Africa—assessment of reproductive health advertisements 2001–2005

, BSc(Pharm), MClinPharm (Independent consultant) & , BPharm, MSc(Pharm)
Pages 53-58 | Published online: 15 Aug 2014

References

  • Avorn J, Chen M, Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med 1982;73(1):4–8.
  • Department of Health. National Drug Policy for South Africa. Pretoria; 1996.
  • Republic of South Africa. Medicines and Related Substances Act (No. 101 of 1965), as amended. Available http://www.mccza.com/documents/Integrated%20Act%20101.zip (accessed 16/11/2007).
  • Minister of Health. Amendment to the General Regulations made in terms of the Medicines and Related Substances Act, 1965 (Act No.101 of 1965), as amended. Notice R.844. Government Gazette No. 26572. 16 July 2004. Government Printer, Pretoria. Available http://www.info.gov.za/regulations/2004/26572/index.html (accessed 16/11/2007).
  • Minister of Health. General Regulations made in terms of the Medicines and Related Substances Act, 1965 (Act No. 101 of 1965), as amended. Notice R.510. Government Gazette No. 24727. 10 April 2003. Available http://www.mccza.com/documents/Regulations%20to%20Act%20101.zip (accessed 16/11/2007).
  • Smith R. Medical journals and pharmaceutical companies: uneasy bedfellows. Br Med J 2003;326:1202–5.
  • Greving JP, Denig P, De Zeeuw D, Haaijer-Ruskamp FM. Claims in advertisements for antihypertensive drugs in a Dutch medical journal. Hypertens 2007;25(3):713–22.
  • Villanueva P, Peiro S, Librero J, Pereiro I. Accuracy of pharmaceutical advertisements in medical journals. Lancet 2003;361:27–32.
  • Van Winkelen P, Van Denderen JS, Vossen CY, Huizinga TWJ, Dekker FW for the SEDUCE study group. How evidence-based are advertisements in journals regarding the subspecialty of rheumatology? Rheumatol 2006;45:1154–7.
  • Loke TW, Koh FC, Ward JE. Pharmaceutical advertising claims in Australian medical publications. Med J Austr 2002;177:291–3.
  • Wilkes MS, Doblin BH, Shapiro M. Pharmaceutical advertisements in leading medical journals: experts' assessments. Ann Intern Med 1992;116:912–9.
  • Cooper RJ, Schriger DL. The availability of references and the sponsorship of original research cited in pharmaceutical advertisements. Can Med Assoc J 2005;172(4):487–91.
  • Gutknecht DR. Evidence-based advertising? A survey of four major journals. J Am Board Fam Pract 2001;14(3):197–200.
  • Harvey KJ, Vitry AI, Roughead E, Aroni R, Ballenden N, Faggotter R. Pharmaceutical advertisements in prescribing software: an analysis. Med J Austr 2005;183(2):75–9.
  • Cardarelli R, Licciardone JC, Taylor LG. A cross-sectional evidence-based review of pharmaceutical promotional marketing brochures and their underlying studies: Is what they tell us important and true? BMC Fam Pract 2006;7:13.
  • Rohra DK, Bashir MU, Khwaja UA, Nazir MR. Critical appraisal of apparently evidence-based written advertising in Pakistan. Pharm World Sci 2007;12 October (e-publication ahead of print).
  • Ferner RE. Watalotwegot—the messages in drug advertising. Br Med J 1994;309:1734–6.
  • Fugh-Berman A, Alladin K, Chow J. Advertising in medical journals: should current practices change? PLoS Medicine 2006;3(6):e130.
  • Cooper RJ, Schriger DL, Wallace RC, Mikulich VJ, Wilkes MS. The quantity and quality of scientific graphs in pharmaceutical advertising. J Gen Intern Med 2003;18:294–7.
  • Lexchin J. Enforcement of codes governing pharmaceutical promotion: what happens when companies breach advertising guidelines. Can Med Assoc J 1997;156(3):351–6.
  • Roughead EE, Gilbert AL, Harvey KJ. Self-regulatory codes of conduct: are they effective in controlling pharmaceutical representatives' presentations to general medical practitioners? Int J Health Serv 1998; 28(2):269–79.
  • Shapiro MF. Regulating pharmaceutical advertising: what will work? Can Med Assoc J 1997;156(3):359–61.
  • Mansfield PR, Lexchin J, Wen LS, et al. Educating health professionals about drug and device promotion: advocates' recommendations. PLoS Medicine 2006;3(11): e451.
  • Mansfield PR. Do advertisements in clinical software influence prescribing? Med J Aust 2008 Jan 7;188(1):13–4.